Atlas Trials

Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST): TKI258

Clinical trial NCT01440959 · COMPLETED

Trial details

NCT number
NCT01440959
Sponsor
Asan Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastrointestinal Stromal Tumors
Start date
2011-09-01
Primary completion
2013-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.